Skip to Main Content

Author Details

Yin Guan
DHC Technologies Co. Ltd.
2008
27
9
PMIDPaper TitleJournal TitlePublished Year
36276102Molecular and clinicopathological characteristics of <i>ERBB2</i> gene fusions in 32,131 Chinese patients with solid tumors.Front Oncol2022
35345821Unraveling COVID-19: A Large-Scale Characterization of 4.5 Million COVID-19 Cases Using CHARYBDIS.Clin Epidemiol2022
36452496Case report: Unique FLT4 variants associated with differential response to anlotinib in angiosarcoma.Front Oncol2022
36247089Exploring Potential Biomarkers, Ferroptosis Mechanisms, and Therapeutic Targets Associated with Cutaneous Squamous Cell Carcinoma via Integrated Transcriptomic Analysis.J Healthc Eng2022
33688639Unraveling COVID-19: a large-scale characterization of 4.5 million COVID-19 cases using CHARYBDIS.Res Sq2021
33569411Comparison of capecitabine-based regimens with platinum-based regimens in Chinese triple-negative breast cancer patients with liver metastasis.Ann Transl Med2021
32894090Bioinformatic analysis reveals hub genes and pathways that promote melanoma metastasis.BMC Cancer2020
33140068Baseline phenotype and 30-day outcomes of people tested for COVID-19: an international network cohort including &gt;3.32 million people tested with real-time PCR and &gt;219,000 tested positive for SARS-CoV-2 in South Korea, Spain and the United States.medRxiv2020
32588429Platinum-based chemotherapy in advanced triple-negative breast cancer: A multicenter real-world study in China.Int J Cancer2020
32782621Clinical outcomes and safety of apatinib monotherapy in the treatment of patients with advanced epithelial ovarian carcinoma who progressed after standard regimens and the analysis of the <i>VEGFR2</i> polymorphism.Oncol Lett2020
31380858A selective and robust UPLC-MS/MS method for the simultaneous quantitative determination of anlotinib, ceritinib and ibrutinib in rat plasma and its application to a pharmacokinetic study.Analyst2019
29131503Association between plasma fibrinogen and survival in patients with small-cell lung carcinoma.Thorac Cancer2018
30588246Potential Management of Circulating Tumor DNA as a Biomarker in Triple-Negative Breast Cancer.J Cancer2018
28084319Tumor-associated immune factors are associated with recurrence and metastasis in non-small cell lung cancer.Cancer Gene Ther2017
26674797[The relationship between anti-phospholipase A2 receptor antibody and idiopathic membranous nephropathy].Zhonghua Nei Ke Za Zhi2015
24398315[Tegafur gimeracil oteracil potassium capsule induced acute interstitial lung disease: a case report].Zhongguo Fei Ai Za Zhi2014
24817304Aryl hydrocarbon receptor exogenous ligand 3-methylchoranthrene inhibited endometrial cancer cells proliferation.Eur Rev Med Pharmacol Sci2014
24926256Fatal interstitial lung disease after addition of sorafenib to a patient with lung adenocarcinoma who had failed to improve with erlotinib alone.Case Rep Oncol2014
24370197Dramatic response to high-dose icotinib in a lung adenocarcinoma patient after erlotinib failure.Lung Cancer2014
24311848A study on anti-tumour effect of Solanum lyratum Thunb. extract in S⿁⿿⿿ tumour-bearing mice.Afr J Tradit Complement Altern Med2013
24311883A study on the effect of ethanol extract of Radix rhapontici on erythrocyte immune function in rats.Afr J Tradit Complement Altern Med2013
22647823Application of 3D-computed tomography angiography technology in large meningioma resection.Asian Pac J Trop Med2012
20463552Genome-wide examination of genetic variants associated with response to platinum-based chemotherapy in patients with small-cell lung cancer.Pharmacogenet Genomics2010
21118971Genome-wide interrogation identifies YAP1 variants associated with survival of small-cell lung cancer patients.Cancer Res2010
18353207[Clinical characteristics and prognostic factors of female breast cancer patients with 10 or more positive lymph nodes: a report of 128 patients].Zhonghua Yi Xue Za Zhi2008
18756935[Analysis of clinicopathological characteristics and prognosis for triple negative breast cancer: a report of 108 cases].Zhonghua Zhong Liu Za Zhi2008
19173993[Clinicopathological characteristics and prognostic factors of breast cancer with estrogen- and progesterone-receptor negative and HER-2 overexpression].Zhonghua Zhong Liu Za Zhi2008
  • 1 - 27 of 27

Recommended Authors

Zhixin Qiu
UPMC Hillman Cancer Center
Career Start Year 2012
Number of shared co-authors 0
Zitong Zhao
School of Pharmacy, Wannan Medical College
Career Start Year 2012
Number of shared co-authors 0
Xing Wang
Shanghai Children's Hospital, Shanghai Jiao Tong University
Career Start Year 2011
Number of shared co-authors 0
Xiangnan Kong
Qilu Hospital of Shandong University
Career Start Year 2011
Number of shared co-authors 0
Bo Gao
Crown Princess Mary Cancer Centre, Westmead Hospital
Career Start Year 2008
Number of shared co-authors 0
Liang Cao
National Cancer Institute, National Institutes of Health
Career Start Year 2008
Number of shared co-authors 0
Shingo Sakashita
National Cancer Center Exploratory Oncology Research & Clinical Trial Center
Career Start Year 2008
Number of shared co-authors 0
Bora Lim
The University of Texas MD Anderson Cancer Center
Career Start Year 2007
Number of shared co-authors 0
Li Liu
Central South University
Career Start Year 2006
Number of shared co-authors 28
Bhumsuk Keam
Seoul National University Hospital
Career Start Year 2006
Number of shared co-authors 0
Naoto Kondo
Nagoya City University Graduate School of Medical Sciences
Career Start Year 2006
Number of shared co-authors 0
Hye Ryun Kim
Yonsei Cancer Center, Yonsei University College of Medicine
Career Start Year 2005
Number of shared co-authors 0
Jeong Eon Lee
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 2004
Number of shared co-authors 1
Fan Zhang
Huaihe Hospital of Henan University
Career Start Year 2004
Number of shared co-authors 0
Wenhua Liang
The First People's Hospital of Zhaoqing
Career Start Year 2003
Number of shared co-authors 0
Jeeyun Lee
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 2003
Number of shared co-authors 0
Yongmei Song
Shandong University of Traditional Chinese Medicine
Career Start Year 2003
Number of shared co-authors 0
Xin Yang
Peking University Cancer Hospital & Institute
Career Start Year 2002
Number of shared co-authors 0
Yongwei Yu
Changhai Hospital
Career Start Year 2001
Number of shared co-authors 0
Wei Zhang
Children's Hospital, Zhejiang University School of Medicine
Career Start Year 2001
Number of shared co-authors 0
Fan Yang
West China Second Hospital, Sichuan University
Career Start Year 2000
Number of shared co-authors 0
Jeong-Won Lee
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 1999
Number of shared co-authors 0
Feng Zhu
Basic Medical College, Qingdao University
Career Start Year 1998
Number of shared co-authors 0
Joon Oh Park
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 1997
Number of shared co-authors 0
Nan Wu
Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University
Career Start Year 1997
Number of shared co-authors 0
Sung Tae Kim
Busan Paik Hospital, Inje University
Career Start Year 1996
Number of shared co-authors 0
Dong Lin
Fujian Medical University Cancer Hospital and Fujian Cancer Hospital
Career Start Year 1996
Number of shared co-authors 0
Hai Hu
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year 1996
Number of shared co-authors 0
Jose A Lopez-Martin
Hospital Universitario 12 de Octubre
Career Start Year 1988
Number of shared co-authors 0
Sun Young Kim
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 1988
Number of shared co-authors 0

Collaborators

Frank DeFalco
Janssen Pharmaceutical Research & Development
Co-authored papers 3
Daniel R Morales
University of Dundee
Co-authored papers 3
George Hripcsak
Columbia University
Co-authored papers 3
Clair Blacketer
Erasmus University Medical Center
Co-authored papers 3
Albert Prats-Uribe
University of Oxford
Co-authored papers 3
Seng Chan You
Yonsei University College of Medicine
Co-authored papers 3
Peter R Rijnbeek
Erasmus University Medical Center
Co-authored papers 3
Andrew E Williams
Tufts, Tufts Medical Center
Co-authored papers 3
Marc A Suchard
University of California los angeles
Co-authored papers 3
Matthew Spotnitz
Columbia University Irving Medical Center
Co-authored papers 3
Thamir M Alshammari
Riyadh Elm University
Co-authored papers 3
Lana Y H Lai
The University of Manchester, University of Manchester
Co-authored papers 3
Adam B Wilcox
Washington University School of Medicine
Co-authored papers 3
Daniel Prieto-Alhambra
University of Oxford
Co-authored papers 3
Vojtech Huser
Lister Hill National Center for Biomedical Communication
Co-authored papers 3
Vignesh Subbian
College of Engineering, University of Arizona
Co-authored papers 3
Kristine E Lynch
University of Utah Health
Co-authored papers 3
Talita Duarte-Salles
Erasmus University Medical Center
Co-authored papers 3
Patrick B Ryan
Columbia University Irving Medical Center
Co-authored papers 3
Jose D Posada
Universidad del Norte
Co-authored papers 3
Fred Nyberg
University of Gothenburg
Co-authored papers 3
Scott L DuVall
University of Utah
Co-authored papers 3
Karthik Natarajan
Columbia University Irving Medical Center
Co-authored papers 3
Asieh Golozar
Northeastern University
Co-authored papers 3
Christian Reich
OHDSI Center at The Roux Institute, Northeastern University
Co-authored papers 3
Nigam H Shah
Stanford University
Co-authored papers 3
Lisa M Schilling
University of Colorado Anschutz Medical Campus
Co-authored papers 3
Michael Matheny
American College of Medical Informatics, Department of Veteran Affairs, Harvard University T H Chan School of Public Health, Massachusetts Institute of Technology, The American Society for Clinical Investigation, University of Kentucky, Vanderbilt University Medical Center, Vanderbilt University Medical School
Co-authored papers 3
Sara Khalid
Botnar Research Centre, University of Oxford
Co-authored papers 2
Jason A Thomas
University of Washington
Co-authored papers 2
Release 1.2